Added to YB: 2024-09-20
Pitch date: 2024-09-20
TARS:US [bullish]
Tarsus Pharmaceuticals, Inc.
+89.31%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.
Market Cap
$2.6B
Pitch Price
$34.62
Price Target
N/A
Dividend
N/A
EV/EBITDA
-26.81
P/E
-30.50
EV/Sales
6.18
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Tarsus Pharmaceuticals, Inc. TARS:US
A summary for this pitch has not been created yet.
Read full article (0 min)